MTEMQ (Molecular Templates) EBITDA Margin %: -3,710.58% (As of Jun. 2024)


MTEMQ Molecular Templates Inc MTEMQ
12 GF Score
Price $0.00
View Full Analysis

What is Molecular Templates EBITDA Margin %?

Molecular Templates MTEMQ 12 EBITDA Margin % is -3,710.58% as of Jun. 2024. GuruFocus rates MTEMQ with a GF Score™ of 12/100.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Molecular Templates's EBITDA for the three months ended in Jun. 2024 was $-7.01 Mil. Molecular Templates's Revenue for the three months ended in Jun. 2024 was $0.19 Mil. Therefore, Molecular Templates's EBITDA margin for the quarter that ended in Jun. 2024 was -3,710.58%.


Molecular Templates  (OTCPK:MTEMQ) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Molecular Templates EBITDA Margin % Related Terms


Molecular Templates EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Molecular Templates's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Molecular Templates EBITDA Margin % Chart

Molecular Templates Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -343.30 -635.04 -188.67 -407.85 2.21

Molecular Templates Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -115.69 -45.62 -41.00 15.79 -3,710.58

MTEMQ vs GRTSQ, ARTHQ, VRTX: EBITDA Margin % Comparison

For the Biotechnology subindustry, Molecular Templates's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Molecular Templates EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Molecular Templates's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Molecular Templates's EBITDA Margin % falls into.


MTEMQ
12GF Score
Molecular Templates Inc MTEMQ
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Molecular Templates EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Molecular Templates's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=1.164/52.625
=2.21 %

Molecular Templates's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-7.013/0.189
=-3,710.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -3,710.58% mean?
Molecular Templates (MTEMQ) has a EBITDA Margin % of -3,710.58% as of Jun. 2024. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Molecular Templates and its competitors.
Is Molecular Templates' EBITDA Margin % too high?
Molecular Templates' current EBITDA Margin % is -3,710.58%. Overall, Molecular Templates has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Molecular Templates' EBITDA Margin % compare to GRTSQ and ARTHQ?
Molecular Templates' EBITDA Margin % of -3,710.58% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Molecular Templates and its competitors. Molecular Templates's current EBITDA Margin % is -3,710.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Molecular Templates stock overvalued right now?
Molecular Templates (MTEMQ) has a current EBITDA Margin % of -3,710.58%. The current EBITDA Margin % is -3,710.58%. Molecular Templates' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Molecular Templates (MTEMQ), the current EBITDA Margin % is -3,710.58% as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Molecular Templates Business Description

Address 9301 Amberglen Boulevard, Suite 100, Austin, TX, USA, 78729
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
12GF Score

Get the complete analysis for MTEMQ

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price